These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18540685)

  • 1. Magnetoresponsive squalenoyl gemcitabine composite nanoparticles for cancer active targeting.
    Arias JL; Reddy LH; Couvreur P
    Langmuir; 2008 Jul; 24(14):7512-9. PubMed ID: 18540685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gemcitabine-based therapy for pancreatic cancer using the squalenoyl nucleoside monophosphate nanoassemblies.
    Maksimenko A; Caron J; Mougin J; Desmaële D; Couvreur P
    Int J Pharm; 2015 Mar; 482(1-2):38-46. PubMed ID: 25448549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of an amphiphilic squalenoyl prodrug of gemcitabine with cellular membranes.
    Bildstein L; Pili B; Marsaud V; Wack S; Meneau F; Lepêtre-Mouelhi S; Desmaële D; Bourgaux C; Couvreur P; Dubernet C
    Eur J Pharm Biopharm; 2011 Nov; 79(3):612-20. PubMed ID: 21784150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new nanomedicine of gemcitabine displays enhanced anticancer activity in sensitive and resistant leukemia types.
    Reddy LH; Dubernet C; Mouelhi SL; Marque PE; Desmaele D; Couvreur P
    J Control Release; 2007 Dec; 124(1-2):20-7. PubMed ID: 17878060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Squalenoyl nanomedicine of gemcitabine is more potent after oral administration in leukemia-bearing rats: study of mechanisms.
    Reddy LH; Ferreira H; Dubernet C; Mouelhi SL; Desmaele D; Rousseau B; Couvreur P
    Anticancer Drugs; 2008 Nov; 19(10):999-1006. PubMed ID: 18827565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmembrane diffusion of gemcitabine by a nanoparticulate squalenoyl prodrug: an original drug delivery pathway.
    Bildstein L; Dubernet C; Marsaud V; Chacun H; Nicolas V; Gueutin C; Sarasin A; Bénech H; Lepêtre-Mouelhi S; Desmaële D; Couvreur P
    J Control Release; 2010 Oct; 147(2):163-70. PubMed ID: 20691740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A unique multidrug nanomedicine made of squalenoyl-gemcitabine and alkyl-lysophospholipid edelfosine.
    Rodríguez-Nogales C; Sebastián V; Irusta S; Desmaële D; Couvreur P; Blanco-Prieto MJ
    Eur J Pharm Biopharm; 2019 Nov; 144():165-173. PubMed ID: 31546021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer efficacy of squalenoyl gemcitabine nanomedicine on 60 human tumor cell panel and on experimental tumor.
    Reddy LH; Renoir JM; Marsaud V; Lepetre-Mouelhi S; Desmaële D; Couvreur P
    Mol Pharm; 2009; 6(5):1526-35. PubMed ID: 19634915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Squalenoylation favorably modifies the in vivo pharmacokinetics and biodistribution of gemcitabine in mice.
    Reddy LH; Khoury H; Paci A; Deroussent A; Ferreira H; Dubernet C; Declèves X; Besnard M; Chacun H; Lepêtre-Mouelhi S; Desmaële D; Rousseau B; Laugier C; Cintrat JC; Vassal G; Couvreur P
    Drug Metab Dispos; 2008 Aug; 36(8):1570-7. PubMed ID: 18474674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Squalene based nanocomposites: a new platform for the design of multifunctional pharmaceutical theragnostics.
    Arias JL; Reddy LH; Othman M; Gillet B; Desmaële D; Zouhiri F; Dosio F; Gref R; Couvreur P
    ACS Nano; 2011 Feb; 5(2):1513-21. PubMed ID: 21275408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interfacial behavior of PEGylated lipids and their effect on the stability of squalenoyl-drug nanoassemblies.
    Bekkara-Aounallah F; Ambike A; Gref R; Couvreur P; Rosilio V
    Int J Pharm; 2014 Aug; 471(1-2):75-82. PubMed ID: 24811925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of a new anticancer prodrug, gemcitabine-squalene, with a model membrane: coupled DSC and XRD study.
    Pili B; Bourgaux C; Amenitsch H; Keller G; Lepêtre-Mouelhi S; Desmaële D; Couvreur P; Ollivon M
    Biochim Biophys Acta; 2010 Aug; 1798(8):1522-32. PubMed ID: 20435013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Freeze-drying of squalenoylated nucleoside analogue nanoparticles.
    Bildstein L; Hillaireau H; Desmaële D; Lepêtre-Mouelhi S; Dubernet C; Couvreur P
    Int J Pharm; 2009 Nov; 381(2):140-5. PubMed ID: 19782881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decoration of Squalenoyl-Gemcitabine Nanoparticles with Squalenyl-Hydroxybisphosphonate for the Treatment of Bone Tumors.
    Rodríguez-Nogales C; Desmaële D; Sebastián V; Couvreur P; Blanco-Prieto MJ
    ChemMedChem; 2021 Dec; 16(24):3730-3738. PubMed ID: 34581019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor.
    Valetti S; Maione F; Mura S; Stella B; Desmaële D; Noiray M; Vergnaud J; Vauthier C; Cattel L; Giraudo E; Couvreur P
    J Control Release; 2014 Oct; 192():29-39. PubMed ID: 24984010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of self-assembled squalenoyl gemcitabine nanoparticles with phospholipid-cholesterol monolayers mimicking a biomembrane.
    Ambike A; Rosilio V; Stella B; Lepêtre-Mouelhi S; Couvreur P
    Langmuir; 2011 Apr; 27(8):4891-9. PubMed ID: 21413743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal squalenoyl-gemcitabine: formulation, characterization and anticancer activity evaluation.
    Pili B; Reddy LH; Bourgaux C; Lepêtre-Mouelhi S; Desmaële D; Couvreur P
    Nanoscale; 2010 Aug; 2(8):1521-6. PubMed ID: 20820745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-assembly of polyisoprenoyl gemcitabine conjugates: influence of supramolecular organization on their biological activity.
    Lepeltier E; Bourgaux C; Maksimenko A; Meneau F; Rosilio V; Sliwinski E; Zouhiri F; Desmaële D; Couvreur P
    Langmuir; 2014 Jun; 30(22):6348-57. PubMed ID: 24835925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterization of poly(ethyl-2-cyanoacrylate) nanoparticles with a magnetic core.
    Arias JL; Gallardo V; Gómez-Lopera SA; Plaza RC; Delgado AV
    J Control Release; 2001 Dec; 77(3):309-21. PubMed ID: 11733098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetite/poly(alkylcyanoacrylate) (core/shell) nanoparticles as 5-Fluorouracil delivery systems for active targeting.
    Arias JL; Gallardo V; Ruiz MA; Delgado AV
    Eur J Pharm Biopharm; 2008 May; 69(1):54-63. PubMed ID: 18164927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.